20-065 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19

The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis.

DARPA FAQs about COVID-19

COVID-19 FAQ – I have a research project idea related to COVID-19. Where should I submit my proposal? DARPA is always interested in new ideas and emerging technologies and solutions. The DARPA technical offices that are focused on these efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.

Defense Sciences Office

The mission of the Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is to identify and create the next generation of scientific discovery by pursuing high-risk, high-payoff research initiatives across a broad spectrum of science and engineering disciplines and transforming these initiatives into disruptive technologies for U.S. national security.

Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of COVID-19 pandemic

PIs within NASA's Earth Science Division (ESD) Research and Analysis (R&A) Applied Sciences Program (ASP), and Earth Science Data Systems Program (ESDS) have begun to explore and/or ask about the possibility of redirecting existing efforts and/or requesting additional support to utilize NASA prodcuts to address the environmental, economic, and/or societal impacts of the COVID-19 pandemic.

COVID-19 FAQs

See question 2: In response to the current need for more COVID-19 information, certain NIFA programs will allow submission of COVID-19 relevant projects outside fof their normal deadlines including: AFRI Foundational Applied Science Requests for Applications, SBIR-Phase I RFA.

NOT-HL-20-757: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

PA-20-135: Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Participating ICs at the time of publication: NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB. Emergency Notices of Special Interest (NOSIs) issued by the respective ICs will specify the activity codes under which recipients can apply. The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster.